S055 Hot Topics
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
The symposium will address those 'hot topics' established by registrant consensus, a true reflection of member concerns and interests. The session will be a 'potpourri' of medical/surgical topics, including some with social and economic import. Expert speakers will provide 'state of the art' material, highlighting recent trends and developments and accenting emerging and innovative therapies. Presentations will be derm relevant, clinically germane, and directly applicable to patient care.
LEARNING OBJECTIVES
Diagnose skin diseases more effectively.
Recognize the medical/surgical implications of those entities, including diagnosis and treatment, especially emerging and innovative therapies.
Apply evolving evidence-based knowledge to patient care.
SCHEDULE
1:00 PM
Melanoma Update 2025
Allan C. Halpern, MD, FAAD
1:20 PM
Atopic Dermatitis: New Developments
Emma Guttman, MD, PhD, FAAD
1:40 PM
Biologics and Psoriasis: The Beat Goes On
Anthony Fernandez, MD, FAAD
2:00 PM
Itch w/o a Rash: What to Do and Why
Shawn Kwatra, MD, FAAD
2:20 PM
Acne & Rosacea: What's New
Amy Flischel, MD, FAAD
2:40 PM
Hairy Matters: What's New in Alopecia
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
3:00 PM
Cosmeceuticals: Naturally Absurd
Nina Nashat Hartman, MD, FAAD
3:20 PM
New Derm Drugs: Use and Abuse
Neal D. Bhatia, MD, FAAD
3:40 PM
AI and Dermatology: The Ups and Downs
Justin Ko, MD, MBA, FAAD
SPEAKERS
Neal D. Bhatia, MD, FAAD
Anthony Fernandez, MD, FAAD
Amy Flischel, MD, FAAD
Emma Guttman, MD, PhD, FAAD
Allan C. Halpern, MD, FAAD
Nina Nashat Hartman, MD, FAAD
Justin Ko, MD, MBA, FAAD
Shawn Kwatra, MD, FAAD
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
Kenneth J. Tomecki, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Neal D. Bhatia, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Aclaris Therapeutics, Inc. – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Alumis – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Consultant(Honoraria); Biofrontera AG – Consultant(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Botanix Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); Castle Biosciences – Consultant(Honoraria); Dermeleve – Consultant (1099 relationship)(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria); Johnson and Johnson Consumer Products Company – Investigator(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Consultant(Honoraria); LEO Pharma, US – Investigator(Grants/Research Funding); Mindera – Investigator(Grants/Research Funding); Nutrafol – Investigator(Grants/Research Funding); Ortho Dermatologics – Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Practical Dermatology – Other(Honoraria); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Soligenix, Inc – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Zerigo Health – Investigator(Grants/Research Funding);
Anthony Fernandez, MD, FAAD
AbbVie – Consultant(Honoraria), Speaker(Honoraria); AstraZeneca – Investigator(Grants/Research Funding); Biogen – Consultant(Honoraria); BMS – Speaker(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Kyowa Kirin – Speaker(Honoraria); Mallinckrodt Pharmaceuticals – Investigator(Grants/Research Funding), Speaker(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Priovant – Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Amy Flischel, MD, FAAD
No financial relationships exist with ineligible companies.
Emma Guttman, MD, PhD, FAAD
AbbVie – Consultant(Fees), Consultant(Honoraria); Almirall – Consultant(Fees), Consultant(Honoraria); Alumis – Consultant (1099 relationship)(Fees); Amgen – Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); AnaptysBio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apollo Therapeutics Ltd – Investigator(Grants/Research Funding); Artax Biopharma – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); ASLAN – Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria); Centrexion Therapeutics Corporation – Consultant (1099 relationship)(Fees); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Connect Biopharma LLC – Consultant(Fees), Consultant(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); Enveda Biosciences – Consultant (1099 relationship)(Fees); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Fees); Galderma Research & Development, LLC – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); Gate Bioscience – Consultant(Honoraria), Consultant (1099 relationship)(Fees); GlaxoSmithKline – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen Biotech – Consultant (1099 relationship)(Fees); Jasper Therapeutics – Consultant (1099 relationship)(Fees); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); Matchpoint Therapeutics – Consultant (1099 relationship)(Fees); Merck – Consultant(Fees), Consultant(Honoraria); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Novartis Pharmaceuticals Corporation – Consultant (1099 relationship)(Fees); NUMAB Therapeutics AG – Consultant (1099 relationship)(Fees); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Fees); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Pharmaxis Ltd – Consultant (1099 relationship)(Fees); Proteologix US Inc – Consultant (1099 relationship)(Fees); RAPT Therapeutics – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria), Consultant (1099 relationship)(Stock Options), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); RibonTherapeutics, Inc., – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); SATO Pharmaceutical Co., Ltd – Consultant(Fees), Consultant(Honoraria); Schro¨dinger, Inc – Consultant (1099 relationship)(Fees); Sitryx – Consultant (1099 relationship)(Fees); Sun Pharma Advanced Research Company (SPARC) – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); Teva – Consultant (1099 relationship)(Fees); Teva Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); TRex Bio – Consultant (1099 relationship)(Fees); UCB – Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); VRG Therapeutics – Consultant (1099 relationship)(Fees); Xencor – Consultant (1099 relationship)(Fees);
Allan C. Halpern, MD, FAAD
Canfield Scientific, Inc. – Consultant(Other Financial Benefit); SpotDoc – Founder(Other Financial Benefit);
Nina Nashat Hartman, MD, FAAD
No financial relationships exist with ineligible companies.
Justin Ko, MD, MBA, FAAD
AbbVie – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees); Enspectra Health – Consultant(Fees); Google Research – Investigator(Grants/Research Funding); Hims – Consultant(Fees); Orlucent – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Fees); Skin Analytics – Consultant(Fees);
Shawn Kwatra, MD, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Castle Biosciences, Inc – Consultant(Honoraria); Galderma – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Kenneth J. Tomecki, MD, FAAD
No financial relationships exist with ineligible companies.